{"id":"https://genegraph.clinicalgenome.org/r/a91eed97-72eb-4cb9-b32e-43220ebfc952v1.0","type":"EvidenceStrengthAssertion","dc:description":"AIMP2 was first reported in relation to neurological disease in 2016 (Helbig et al. 2016) and specifically related to autosomal recessive hypomyelinating leukodystrophy 17 (OMIM:600859) in 2018 (Shukla et al. 2018, PMID: 29215095). AIMP2 protein function is a non-enzymatic factor that is required for the assembly and stability of the aminoacyl-tRNA synthetase complex (NCBI). This disease is clinically characterized by severe infantile onset neurodevelopmental disorders with seizures, microcephaly, and white matter abnormality on MRI and additional variable findings including global developmental delay, intellectual disability, contractures, spasticity, feeding difficulties, and facial dysmorphisms (PMIDs: 26795593, 29215095, 35568357, 35140751, 38374194). \n\nPer criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanisms or inheritance pattern, and therefore the single disease entity of HLD17 has been maintained. The mechanism of pathogenicity is loss of function. Six variants (2 frameshift, 2 nonsense, 1 missense, 1 splice-site) that have been reported in 7 probands in 5 publications (PMIDs: 26795593, 29215095, 35568357, 35140751, 38374194) are included in this curation. Of note, one variant (c.105C>A; Tyr35*) was observed in three probands of Indian descent and is likely a founder variant in this population. \n\nThis gene-disease relationship is also supported by protein interaction and biochemical function experiments (Kim et al., PMID: 12060739). In immunoprecipitation studies, Kim et al. showed that Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 2 (called p38 in their publication) binds to QARS1, which has been definitively associated with recessive hypomyelinating leukodystrophy 3 by the Leukodystrophy and Leukoencephalopathy GCEP.  Additionally, Kim et al. showed the protein encoded AIMP2 also associated with the protein encoded by the AIMP1 gene in the multi-ARS complex, which has a definitive curation for hypomyelinating leukodystrophy 3 (PMID: 12060739). In addition, Ochiai et al 2022 demonstrated that mouse brain oligodendroglial cells with an AIMP2 homozygous variant failed to differentiate appropriately to form oligodendroglial processes required to form myelin, and therefore exhibit a process similar to hypomyelination seen in humans. In summary, there is definitive evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Leukodystrophy GCEP on the meeting date June 11, 2025 (SOP Version 11).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/a91eed97-72eb-4cb9-b32e-43220ebfc952","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ba6f8aa3-9aa9-4755-8dec-bb5c69005bbe","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ba6f8aa3-9aa9-4755-8dec-bb5c69005bbe_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2025-09-03T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ba6f8aa3-9aa9-4755-8dec-bb5c69005bbe_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2025-09-03T18:32:51.830Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba6f8aa3-9aa9-4755-8dec-bb5c69005bbe_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e81324e8-fa9a-4282-a808-285e3855f450_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04a32d59-35f0-4194-b4b6-57ff19daed8e","type":"EvidenceLine","dc:description":"Did not upgrade for functional data and capped each proband at 2 points per GCEP guidelines","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04a32d59-35f0-4194-b4b6-57ff19daed8e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant decreases mRNA levels in patients compared to controls, however the difference was not statistically significant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/04a32d59-35f0-4194-b4b6-57ff19daed8e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29215095","allele":{"id":"https://genegraph.clinicalgenome.org/r/11db1b25-4d0d-4196-a358-e8f18e903801","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006303.4(AIMP2):c.105C>A (p.Tyr35Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA366745462"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e81324e8-fa9a-4282-a808-285e3855f450","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29215095","rdfs:label":"Shulka_Family1_Patient1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/11db1b25-4d0d-4196-a358-e8f18e903801"},"detectionMethod":"Whole exome sequencing on peripheral leukocyte DNA with Sanger sequencing used to validate the variant","firstTestingMethod":"Exome sequencing","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/04a32d59-35f0-4194-b4b6-57ff19daed8e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bbac56a7-9b5b-44bd-98d7-9f075ab4335a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19aa7f02-9e38-4d5e-8db3-39a6008520fe","type":"EvidenceLine","dc:description":"Downgraded 0.5 points because variant escapes NMD, max of 2 points per proband so capped this at 0.5","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19aa7f02-9e38-4d5e-8db3-39a6008520fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26795593","allele":{"id":"https://genegraph.clinicalgenome.org/r/74357cff-77ea-4be1-b8fd-129ad4071696","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006303.4(AIMP2):c.575-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358225"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d29fa425-8006-4da9-b0ff-d22b974fdcf9","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d29fa425-8006-4da9-b0ff-d22b974fdcf9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26795593","allele":{"id":"https://genegraph.clinicalgenome.org/r/cc82e546-fd0c-4ef3-bdf5-e90eea482773","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006303.4(AIMP2):c.72_73del (p.Met24IlefsTer25)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139659974"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bbac56a7-9b5b-44bd-98d7-9f075ab4335a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26795593","rdfs:label":"Helbig_Patient106","allele":[{"id":"https://genegraph.clinicalgenome.org/r/cc82e546-fd0c-4ef3-bdf5-e90eea482773"},{"id":"https://genegraph.clinicalgenome.org/r/74357cff-77ea-4be1-b8fd-129ad4071696"}],"detectionMethod":"Whole exome sequencing with identified candidate alterations confirmed\nusing automated fluorescence dideoxy sequencing","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012469","obo:HP_0001250","obo:HP_0200134"],"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d29fa425-8006-4da9-b0ff-d22b974fdcf9_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/19aa7f02-9e38-4d5e-8db3-39a6008520fe_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/3e796ddf-e280-487c-94b2-58e0e52ab155_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9d632c8-0f72-4438-9262-28ab220adaf7","type":"EvidenceLine","dc:description":"Variant is in the last exon and is expected to escape NMD, so downgrade to 1 point per variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9d632c8-0f72-4438-9262-28ab220adaf7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35140751","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdb833fa-834e-4b8a-8ef5-d39e1eaa63f2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006303.4(AIMP2):c.670A>T (p.Lys224Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA366747771"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3e796ddf-e280-487c-94b2-58e0e52ab155","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35140751","rdfs:label":"Mazaheri_Patient1","ageType":"AgeAtReport","ageUnit":"Months","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/fdb833fa-834e-4b8a-8ef5-d39e1eaa63f2"},"detectionMethod":"Whole-exome sequencing (WES) was performed on the proband. Parental samples were analyzed by PCR amplification and Sanger sequencing.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Tilted ankle, Delayed cry at birth, Delayed myelination of brain parenchyma\n","phenotypes":["obo:HP_0001824","obo:HP_0012704","obo:HP_0000252","obo:HP_0012447","obo:HP_0002120","obo:HP_0006808","obo:HP_0007082","obo:HP_0001903","obo:HP_0009815","obo:HP_0012444","obo:HP_0006956"],"secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d9d632c8-0f72-4438-9262-28ab220adaf7_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ba6f8aa3-9aa9-4755-8dec-bb5c69005bbe_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7a839ab-efb7-420a-b541-846d094b89bf_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29215095","rdfs:label":"Shukla_Family_1","family":{"id":"https://genegraph.clinicalgenome.org/r/e7a839ab-efb7-420a-b541-846d094b89bf","type":"Family","rdfs:label":"Shukla_Family_1","member":{"id":"https://genegraph.clinicalgenome.org/r/e81324e8-fa9a-4282-a808-285e3855f450"}},"phenotypeFreeText":"basal ganglia hypointensities","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002828","obo:HP_0000215","obo:HP_0002120","obo:HP_0005876","obo:HP_0001257","obo:HP_0002280","obo:HP_0000179","obo:HP_0011344","obo:HP_0001285","obo:HP_0004880","obo:HP_0009765","obo:HP_0006827","obo:HP_0001272","obo:HP_0031165","obo:HP_0002751","obo:HP_0012447","obo:HP_0033725","obo:HP_0011968","obo:HP_0000252","obo:HP_0001249","obo:HP_0002505"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e81324e8-fa9a-4282-a808-285e3855f450"}},{"id":"https://genegraph.clinicalgenome.org/r/e468033b-e703-4349-b9e7-978686a71940_proband_segregation","type":"FamilyCosegregation","dc:description":"At least 3 affected individuals are needed to count segregations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29215095","rdfs:label":"Shukla_Family_2","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/e468033b-e703-4349-b9e7-978686a71940","type":"Family","rdfs:label":"Shukla_Family_2","member":{"id":"https://genegraph.clinicalgenome.org/r/bdabee2f-eedf-4336-aabe-3cd8dee8be08","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29215095","rdfs:label":"Shulka_Family2_Patient2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/11db1b25-4d0d-4196-a358-e8f18e903801"},"detectionMethod":"Whole exome sequencing on peripheral leukocyte DNA with Sanger sequencing to validate the variants","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Paucity of white matter and bilateral symmetrical areas of altered signal intensities in periventricular white matter suggestive of demyelination","phenotypes":["obo:HP_0031165","obo:HP_0012447","obo:HP_0032792","obo:HP_0002505","obo:HP_0011344","obo:HP_0011968","obo:HP_0002521","obo:HP_0002120","obo:HP_0001249","obo:HP_0004880","obo:HP_0000252","obo:HP_0001257"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7ae43353-5786-4a65-adbf-4223c6ea52ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29215095","allele":{"id":"https://genegraph.clinicalgenome.org/r/11db1b25-4d0d-4196-a358-e8f18e903801"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002521","obo:HP_0001257","obo:HP_0001249","obo:HP_0011344","obo:HP_0012447","obo:HP_0000252","obo:HP_0011968","obo:HP_0002505","obo:HP_0002120","obo:HP_0004880"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/bdabee2f-eedf-4336-aabe-3cd8dee8be08"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/bdabee2f-eedf-4336-aabe-3cd8dee8be08_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ae43353-5786-4a65-adbf-4223c6ea52ad","type":"EvidenceLine","dc:description":"Did not upgrade for functional data and capped each proband at 2 points per GCEP guidelines","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ae43353-5786-4a65-adbf-4223c6ea52ad_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant shows decreased mRNA expression but in levels not statistically significant from controls ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7ae43353-5786-4a65-adbf-4223c6ea52ad_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bdabee2f-eedf-4336-aabe-3cd8dee8be08"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/65a1a065-2b66-4ebc-b2d3-bd0432b3958a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b5bf585-4eaf-4479-9a02-ca94bad060f0","type":"EvidenceLine","dc:description":"GCEP caps points per proband at 2","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b5bf585-4eaf-4479-9a02-ca94bad060f0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38374194","allele":{"id":"https://genegraph.clinicalgenome.org/r/b0a77e92-e07d-463f-a065-8e445043bbdb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006303.4(AIMP2):c.34_35delinsC (p.Gly12ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2837994529"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/65a1a065-2b66-4ebc-b2d3-bd0432b3958a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38374194","rdfs:label":"Abolhassani_Patient925","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b0a77e92-e07d-463f-a065-8e445043bbdb"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000602","obo:HP_0001276","obo:HP_0000505","obo:HP_0001250","obo:HP_0001249","obo:HP_0001622","obo:HP_0000486","obo:HP_0001903","obo:HP_0001270","obo:HP_0011344","obo:HP_0003690","obo:HP_0000252","obo:HP_0001257"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8b5bf585-4eaf-4479-9a02-ca94bad060f0_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e6c7c2e9-768c-4ac8-b086-a7dab9a47cae_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/889c2d26-21aa-4e3e-8b09-10ec7fb334e8","type":"EvidenceLine","dc:description":"Missense variant (homozygous) in a consanguineous family. In addition, GCEP decided not to score due to incomplete phenotype data as the proband is part of a larger microcephaly cohort and the paper does not specifically mention hypomyelination","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/889c2d26-21aa-4e3e-8b09-10ec7fb334e8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35568357","allele":{"id":"https://genegraph.clinicalgenome.org/r/9d4f6a2b-fdb8-4d4e-8569-c2379a4f855e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006303.4(AIMP2):c.74A>G (p.Tyr25Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA366745404"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e6c7c2e9-768c-4ac8-b086-a7dab9a47cae","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35568357","rdfs:label":"Masih_F32.1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9d4f6a2b-fdb8-4d4e-8569-c2379a4f855e"},"detectionMethod":"Exome sequencing with Sanger sequencing of putative variants in the index patient and other family members for validation and segregation analysis","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0005876","obo:HP_0011344","obo:HP_0400001","obo:HP_0001249","obo:HP_0000252","obo:HP_0033725","obo:HP_0011968","obo:HP_0000574","obo:HP_0025190","obo:HP_0000278","obo:HP_0000527","obo:HP_0000426","obo:HP_0011335","obo:HP_0002521","obo:HP_0000664","obo:HP_0002553"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/889c2d26-21aa-4e3e-8b09-10ec7fb334e8_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10},{"id":"https://genegraph.clinicalgenome.org/r/ba6f8aa3-9aa9-4755-8dec-bb5c69005bbe_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba6f8aa3-9aa9-4755-8dec-bb5c69005bbe_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddd3d7a5-2754-429f-a9a1-9d7f802a9332","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4356ca36-f5ff-4168-a23c-59b87dd138c3","type":"Finding","dc:description":"loss of morphological differentiation leads to inability to produce myelin, consistent with human phenotype of hypomyelination","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34523057","rdfs:label":"Differentiation of Oligodendroglial Cell ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ba6f8aa3-9aa9-4755-8dec-bb5c69005bbe_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5298fc8-8399-44fb-a914-d782a095b168","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d316e05-2e7b-4dcd-8b3c-f65be65ec7cd","type":"Finding","dc:description":"AIMP1 is also part of the multi-tRNA synthase complex ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12060739","rdfs:label":"Kim_AIMP1_Protein_Interaction","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/737a86d6-5d21-40de-83e3-6660bd7ef979","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/966af77c-8e9d-4619-8c58-d2e758e86bb9","type":"Finding","dc:description":"Immunoprecipitation of p38 in HEK293 cells shows other proteins, including QARS1, bind to the multi-ARS complex","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12060739","rdfs:label":"Kim_Immunoprecipitation","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Definitive","sequence":11479,"specifiedBy":"GeneValidityCriteria11","strengthScore":12,"subject":{"id":"https://genegraph.clinicalgenome.org/r/lcZ0EMjuzYk","type":"GeneValidityProposition","disease":"obo:MONDO_0054817","gene":"hgnc:20609","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ba6f8aa3-9aa9-4755-8dec-bb5c69005bbe-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}